1. Denmark Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Scandinavian Medical Solutions A/S

Scandinavian Medical Solutions A/S

CCPH:SMSMED
2.50
DKK
0.00
(0.00%)
90.65MMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.14
1.54
2.63
4.14
7
8.26
8.88
- -
Basic EPS, GAAP
0.11
0.17
0.3
0.43
0.45
0.28
- -
- -
Free Cash Flow per Basic Share
- -
0.34
0.15
-0.91
-1.8
-0.55
-1.24
- -
Dividend per Share
- -
- -
0.17
- -
- -
- -
- -
- -
Book Value per Share
0.12
0.18
0.88
2.28
2.73
3
2.99
2.62
Tangible Book Value per Share
0.12
0.18
0.88
2.28
2.73
3
2.99
2.62
Basic Weighted Avg Shares
27
27
27
27
27
27
28
28
Sales/Revenue/Turnover
31
42
72
111
191
227
245
- -
Operating Margin (%)
12.49
14.22
15.18
13.34
8.7
6.07
0.73
- -
Depreciation Expense
- -
- -
- -
1
4
7
9
- -
Net Income, GAAP
3
5
8
11
12
8
- -
- -
Effective Tax Rate (%)
22.14
22.46
22.61
22.7
22.6
22.66
87.91
- -
Profit Margin (%)
9.74
10.75
11.39
10.29
6.39
3.44
0.01
- -
Working Capital
3
5
24
52
43
44
51
41
LT Debt
- -
- -
- -
- -
18
13
30
35
Total Equity
3
5
24
62
74
82
83
73
Return on Invested Capital (%)
- -
78.92
49.34
25
14.74
9.14
0.16
- -
Return on Capital (%)
- -
108.89
58.02
26.78
15.7
10.53
0.21
- -
Return on Common Equity (%)
- -
112.51
56.28
26.36
17.89
9.92
0.03
- -

Capital Structure

DKK

•

in mil. unless spec.
Mar'25
Sep'25
Mar'26
ST Debt
19
33
39
LT Borrowings
- -
- -
- -
LT Finance Leases
29
30
35
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
28
28
28
Market Capitalization
120
110
91

Working Capital

DKK

•

in mil. unless spec.
Mar'25
Sep'25
Mar'26
Total Current Assets
124
142
129
Cash, Cash Equivalents & STI
- -
2
1
Accounts Receivable, Net
27
23
17
Inventories
80
106
98
Total Current Liabilities
71
91
89
Payables & Accruals
- -
- -
- -
ST Debt
19
33
39
Deferred Revenue
- -
- -
- -

Growth Rates

DKK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
116.53%
0.22%
Free Cash Flow
- -
-120.38%
126.97%
Net Income, GAAP
- -
-1.65%
-99.67%
Sales/Revenue/Turnover
- -
44.98%
8.28%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
227
2025
- -
- -
245
2026
- -
- -
- -

Semi-annual Earnings Per Share

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
0.28
2025
- -
- -
- -
2026
- -
- -
- -

Semi-annual Dividends Per Share

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Paulsen Jens Hvid
Full Time Employees
31
Sector
Distribution services
Industry
Medical distributors
Address
Gasvaerksvej 46 Aalborg ND Denmark 9000
IPO Date
Nov 3, 2021
Website
scandinavian-medical.com
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Scandinavian Medical Solutions A/S is a Denmark-based supplier of pre-owned diagnostic imaging equipment and related healthcare solutions that enables healthcare providers to deliver cost-effective medical services worldwide. Founded in 2018 and headquartered in Aalborg, Denmark, the company offers high-quality used systems including magnetic resonance imaging (MRI) scanners, computed tomography (CT) machines, positron emission tomography/computed tomography (PET-CT) scanners, cardiac/vascular (C/V) suites, radiofrequency (RF)/X-ray systems, C-arms, ultrasound devices, linear accelerators, and mammograms; it also provides spare parts solutions, flexible rental options, technical services, installation, and complete business-to-business logistics such as deinstallation, transport, and quality assurance for ton-heavy equipment. Scandinavian Medical Solutions serves hospitals, medical clinics, and distributors globally from its operations in Europe and a U.S. subsidiary based in California, which optimizes logistics for North and South American markets. In early 2024, the company launched its U.S. subsidiary following an announcement in November 2023, with founder Jens Krohn assuming the role of CEO there and Jens Hvid Paulsen taking over as CEO of the parent entity; additionally, in September 2025, it secured a significant order valued between DKK 2 million and DKK 3.5 million for a Siemens PET/CT scanner sold to a new American partner, underscoring its expanding presence in the Americas. The company, listed on Nasdaq First North Growth Market Denmark under ticker SMSMED.CO since November 2021, continues to pursue strategic growth amid competitive pressures and macroeconomic challenges affecting buyer demand.